As discussed in Note 1, upon completion of the Company’s IPO in June 2021, the Company sold 32,800 shares of common stock at an offering price of $18.00 per share.

In connection with the IPO, the Company increased its authorized shares from 1 to 800,000 shares of common stock, par value $0.01 per share.

The Company’s common stock/units consisted of the following common units and common stock as of the periods ended June 30, 2021 (Successor) and December 31, 2020 (Successor):


	Redeemable Class A Units			Class A-1 Units			Class A-2 Units			Class B Units			Common Stock		Total
Balance as of April 13, 2020 (Successor)		—			—			—			—			—		—
Issued		35,000			959,563			49,946			—			—		1,044,509
Balance as of December 31, 2020		35,000			959,563			49,946			—			—		1,044,509
Issued		—			—			1,687			—			—		1,687
Vested Class B Profits Interests		—			—			—			17,920			—		17,920
Conversion of pre-IPO units to common stock		(35,000	)		(959,563	)		(51,633	)		(17,920	)		340,849		(723,267	)
Initial Public Offering		—			—			—			—			32,800		32,800
Endowment to the LifeStance Health Foundation		—			—			—			—			500		500
Balance as of June 30, 2021 (Successor)		—			—			—			—			374,149		374,149

Upon the closing of the TPG Acquisition, the Company initiated two share exchanges for all outstanding shares, including Class A and Class C Units, as well as Series A and Series A-1 Preferred Units. Subsequent to the share exchanges, holders of the units received cash consideration for a portion of their units, and the remaining units were exchanged for Class A-1 and Class A-2 units of LifeStance TopCo based on a predetermined exchange ratio. There were approximately 345,978 and 35,845 Class A-1 and Class A-2 units outstanding, respectively, as a result of the exchange of equity on May 14, 2020. No Class A Units or Class C Units were outstanding after the TPG Acquisition as a result of the conversion.

The chief executive officer (“CEO”) had 35,000 redeemable Class A units outstanding prior to the completion of the IPO. The CEO had the right, upon termination for any reason other than proper cause, to put his redeemable Class A units back to the partnership at fair value (“Put Right”). The CEO (or permitted transferee) shall have this Put Right also upon death or disability. As this was both outside of the Company’s control and probable to eventually occur, the redeemable Class A units subject to this Put Right were classified as mezzanine equity and carried at fair value (i.e., redemption price). There was a change to the fair value during the period from April 1 to June 9, 2021 (Successor) and the period from January 1 to June 9, 2021 (Successor) of $0 and $36,750, respectively, resulting from a change in the probability assumption of an IPO. On June 9, 2021, the redeemable Class A units were converted into 10,234 shares of the Company’s common stock.

Class A-1 Common Units had equal voting rights. Class A-2 and Class B Common Units were nonvoting units.

In connection with the Company’s IPO, the Company authorized the issuance of 25,000 shares of its preferred stock, par value $0.01 per share. There are no shares of preferred stock outstanding as of June 30, 2021 (Successor).